Millions of deaths and ongoing illnesses caused by the COVID-19 pandemic have prompted scientists to seek new ways of understanding how viruses so skillfully enter and reprogram human cells.
Immutep picks up more funds for LAG-3 oncology and autoimmune studies
Immutep has raised about $53 million to bankroll its LAG-3 drugs across oncology and autoimmune diseases, giving it a cash runway to the first quarter